Lydia completed her BSc in Physiological Science at the University of Bristol and joined Hanson Wade in 2018 as a Conference Producer. Lydia is now a Brand Director within the CNS & Inflammation Business Unit and focuses on understanding the latest trends and advances in CNS drug development. Lydia is responsible for expanding Hanson Wade’s footprint and reputation in neurology and ophthalmology, thus creating new opportunities for the development of her team.